About us

We at CarthroniX strive to understand the intrinsic linkage between inflammation, regeneration and aging.

This fundamental knowledge will enable us to greatly reduce the impact of age-related illnesses within a generation. We are dedicated to extending your physical activity and health, and spirit to provide each of us with more time to enjoy this beautiful journey of life.
Hassan Serhan, Ph.D.
CEO/Board Member
Hassan is part of CarthroniX executive team with deep expertise in spine and orthopedics, technology evaluation and development, and executive level management of large programs in complex corporate environments. He serves as the Chairman of the Board of DisCure Medical, Chairman of the Scientific & Clinical Advisory Board at Intelligent Implants, Strategic Advisor for MDRisks, and retained Advisor for Rosiesbase a subsidiary of Komatsuseiki Kosakusho. Past positions included Distinguished Engineering Fellow, Senior Director, Research & Technology, at DePuy Synthes Spine a Johnson & Johnson company, an Assistant Research Professor with the Neurosurgery & Orthopedic Departments at SUNY University. Hassan is the Co-Founder and Treasurer of the International Musculoskeletal Society (I.M.S.) and a Prestige Adjunct Professor at the Bioengineering Department University of Toledo OH.
Dr. Denis A. Evseenko, MD, Ph.D.
Co-Founder/President/Chair of Scientific & Clinical Advisory Board

Dr. Denis Evseenko is currently a Professor and Vice Chair for Research at the Department of Orthopaedic Surgery at the Keck School of Medicine at University of Southern California, Los Angeles. Dr. Evseenko was trained in both medicine and molecular pharmacology. His research focuses on the development of novel translational stem cell and small molecule-based approaches for prevention of arthritis, aging as well as the enhancement of tissue regeneration. Dr Evseenko has been involved in translational medical research and entrepreneurial activities for over 10 years and is the author of numerous peer-reviewed research articles, presentations and patents.

R. Rex Parris
Founding Investor/Attorney
Mr. R. Rex Parris Esq. is the founder of Parris Law and the Mayor of Lancaster, California.  Lancaster became the first net zero mid-size city in the world under his leadership.  He formed public/private partnerships with green energy companies and is successfully converting all of the city’s energy needs to green energy.  He recently was named the Green Power Leader of the nation by the United States Environmental Protection Agency. He now is directing his energies to help eliminate inflammatory disease.  Mr. Parris approach to solutions is a simple approach:  “Find the smartest people in the field who work tirelessly.  Then get them the funding to do their work. My job is to deal with the bureaucratic obstacles.  It worked with putting a dent in climate extinction, and it will work with eliminating inflammatory disease.”
Dr. Ben Van Handel, Ph.D.
VP on R&D/Chief Scientific Officer/Co-Founder/Board Member
Dr. Ben Van Handel is a highly-awarded stem cell scientist and entrepreneur. He earned his B.S. Degree in Biochemistry from Northern Michigan University and his Ph.D. in molecular, cell and developmental biology at UCLA. He started his first company during graduate school and has gone on to found two others, serving as the CEO of all three and raising millions of dollars in capital and successfully bringing highly innovative products to the market. He has published over 30 papers in the fields of regenerative medicine and stem cell biology that have been cited over 2,500 times. Dr. Van Handel enjoys staying active, roasting coffee, and spending time with his beagle Yeti.
Irina A. Kaydanik
Board Member/General Manager
Mrs. Irina Kaydanik is a seasoned professional with over 20 years of international experience in nonprofit and business development. She obtained her Master in Management and Employment Relations from the University of Auckland (New Zealand) and a postgraduate diploma in Human Resources Management from the University of California Los Angeles (UCLA). Irina is a strong leader, successful entrepreneur, and environmental advocate. She oversees CarthroniX operations and works on developing first-in-class true stem cell luxury cosmetic line Heraux.
Dr. Denis A. Evseenko, MD, Ph.D.
Vice Chair for Research, Director of Skeletal Regeneration Program, Professor of Orthopaedic Surgery, Regenerative Medicine and Stem Cell Biology, Keck School of Medicine, USC, Los Angeles.
Dr. Evseenko is a pioneer in stem cell biology, regenerative medicine and pharmacology; He has made significant fundamental contributions to the area of musculoskeletal biology and disease; Dr. Evseenko has invented several novel prospective cell-based and small-molecule-based therapies for arthritis and articular cartilage regeneration. He is the author of numerous peer-reviewed research articles, presentations and patents.
Dr. Mark G. Rubin, MD
Private Practice Lasky Skin Center, Beverly Hills, Emeritus Assistant Clinical Professor Of Dermatology At The UC San Diego.
A Beverly Hills Board Certified Dermatologist, Dr. Rubin is an expert in innovative therapies and personalized care for conditions of the skin, with a particular interest in skin rejuvenation. He has been in practice for more than 20 years. Dr. Rubin has written multiple papers, book chapters, and a textbook on skin rejuvenation. He has also personally trained over 600 physicians in his technique of skin rejuvenation. He is an international lecturer and has presented his ideas and research in over ten countries. In addition to his work with patients, Dr. Rubin also performs clinical research projects and works as a consultant for various skincare and medical device companies.
C. Thomas Vangsness, Jr., MD
Professor in the Department of Orthopaedic Surgery, Keck School of Medicine, USC, Los Angeles.
Dr. Vangsness is a board certified orthopedic surgeon and internationally recognized for his expertise in shoulder and knee surgery. He has conducted and published extensive research with a focus on such topics as shoulder and ligament biomechanics, stem cell biology, allograft transplantation, and meniscal cartilage. He directed multiple clinical trials focused on osteoarthritis and cartilage restoration. He is the author of the critically acclaimed book “The New Science of Overcoming Arthritis”.
Frank Petrigliano, MD
Associate Professor of of Clinical Orthopaedic Surgery; Chief of the Epstein Family Center for Sports Medicine at Keck Medicine of USC, Los Angeles.
Dr. Petrigliano is an Associate Professor of Clinical Orthopaedic Surgery and Chief of the Epstein Family Center for Sports Medicine at Keck Medicine of USC. He serves as the head team physician for the LA Kings hockey team and a team physician for USC Athletics. He specializes in the care of injuries of the shoulder, knee, and elbow. A native of New York, Dr. Petrigliano completed his undergraduate training at Cornell University where he graduated with honors. Dr. Petrigliano then attended the Rutgers Robert Wood Johnson Medical School for his medical training and his residency in Orthopaedic Surgery at UCLA. After residency, Dr. Petrigliano completed a fellowship in Sports Medicine and Shoulder Surgery at the prestigious Hospital for Special Surgery and Weill Cornell Medical College in New York City where he assisted in the care of the Brooklyn Nets and Iona College Athletics. Dr. Petrigliano has authored over one hundred articles, chapters, and peer-reviewed publications on shoulder, elbow, and knee injuries in athletes.
Gregory Sieczkiewicz, Ph.D, J.D.
Chief IP Counsel
Greg has extensive experience working with venture capital firms, venture-backed life sciences startups, and public biotechnology companies.  Greg is also Chief IP Counsel at MPM Capital. He has served as Vice President, IP at Flagship Ventures, and also practiced patent prosecution and enforcement at national law firms Mintz Levin, Proskauer Rose and Foley Hoag. Greg is a member of the bar of the Commonwealth of Massachusetts and is admitted to practice before the U.S. Patent and Trademark Office. He is also the former President of the Boston Patent Law Association.